Definium Therapeutics Market Sentiment

Definium Therapeutics Inc

DFTXNASDAQ

Trade with Public

$36.88

0.150.41%

最終更新: Sep 25, 9:09 AM

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Definium Therapeutics Market Sentiment

Market sentiment signals for Definium Therapeutics (DFTX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 8.9% short float

Options Flow— N/A

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

15 analysts

Options Flow (P/C)

—

Avg Consensus PT

$64

+72.3%

Highest Price Target

$90

+144.0%

Jones Trading

Lowest Price Target

$25

-32.2%

Wolfe Research

Short Interest

8.9%

Rising — Bearish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 15, 2026	Canaccord Genuity	Sumant Kulkarni—	+111.5%	$64 → $78	Maintained	Buy
Sep 15, 2026	Baird	Christopher Chen—	+114.2%	$75 → $79	Maintained	Outperform
Sep 14, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+89.8%	$70 → $70	Maintained	Buy
Sep 14, 2026	Needham	Ami Fadia—	+79.0%	$66 → $66	Maintained	Buy
Sep 11, 2026	RBC Capital	Brian Abrahams—	+79.0%	$66 → $66	Maintained	Outperform
Aug 18, 2026	B of A Securities	Tazeen Ahmad—	+103.4%	$75	Initiate	Buy
Aug 14, 2026	Maxim Group	——	+49.1%	$50 → $55	Maintained	Buy
Aug 13, 2026	Jones Trading	Justin Walsh—	+144.0%	$74 → $90	Maintained	Buy
Aug 13, 2026	Canaccord Genuity	Sumant Kulkarni—	+73.5%	$58 → $64	Maintained	Buy
Aug 13, 2026	RBC Capital	Brian Abrahams—	+79.0%	$57 → $66	Maintained	Outperform
Aug 13, 2026	Wells Fargo	Benjamin Burnett—	+95.2%	$68 → $72	Maintained	Overweight
Aug 13, 2026	Baird	Christopher Chen—	+103.4%	$57 → $75	Maintained	Outperform
Aug 12, 2026	Needham	Ami Fadia—	+79.0%	$50 → $66	Maintained	Buy
Aug 7, 2026	Piper Sandler	David Amsellem—	+103.4%	$73 → $75	Maintained	Overweight
Jul 27, 2026	Wells Fargo	Benjamin Burnett—	+84.4%	$68	Initiate	Overweight
Jul 24, 2026	Piper Sandler	David Amsellem—	+97.9%	$48 → $73	Maintained	Overweight
Jul 8, 2026	Stifel	Paul Matteis—	+62.7%	$30 → $60	Maintained	Buy
Jun 30, 2026	Canaccord Genuity	Sumant Kulkarni—	+57.3%	$60 → $58	Maintained	Buy
Jun 24, 2026	Jones Trading	Justin Walsh—	+100.7%	$61 → $74	Maintained	Buy
Jun 23, 2026	Baird	Christopher Chen—	+54.6%	$37 → $57	Maintained	Outperform
Jun 23, 2026	Needham	Ami Fadia—	+35.6%	$38 → $50	Maintained	Buy
Jun 22, 2026	Leerink Partners	Marc Goodman—	+41.0%	$30 → $52	Maintained	Outperform
Jun 22, 2026	Oppenheimer	Jay Olson—	+62.7%	$40 → $60	Maintained	Outperform
Jun 16, 2026	Canaccord Genuity	Sumant Kulkarni—	+3.0%	$38 → $38	Maintained	Buy
May 8, 2026	Piper Sandler	David Amsellem—	+30.2%	$49 → $48	Maintained	Overweight

More with Benzinga EdgeGet Access

Insider & Market Activity News

9 Health Care Stocks With Whale Alerts In Today's Session

Benzinga Insights

Definium Therapeutics Inc

Definium Therapeutics Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

Insider & Market Activity News

9 Health Care Stocks With Whale Alerts In Today's Session

People Also Watch

ニュース

パートナーシップ

ベンジンガ・グローバル

Bulls vs Bears

People Also Watch